Premium
Comparison between the short‐term outcomes of bevacizumab and ziv‐aflibercept in the treatment of primary diabetic macular oedema
Author(s) -
Ashraf Mohammed,
El Kayal Hassan,
Souka Ahmed A.R.
Publication year - 2017
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/aos.13352
Subject(s) - aflibercept , medicine , bevacizumab , ophthalmology , diabetic retinopathy , visual acuity , randomized controlled trial , clinical trial , surgery , diabetes mellitus , chemotherapy , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom